Matthew Locke

Matthew Locke is a Global Study Manager at AstraZeneca, currently supporting the delivery of early phase oncology multi-centre clinical trials. Their responsibilities include the development of study documents, vendor management, and oversight of supplies and recruitment. Previously, Matthew spent over five years at the University of Cambridge, where they coordinated academic clinical studies in MRI/Radiology, including research on a novel imaging agent for tumor metabolism. Matthew completed a Bachelor’s Degree via the Open University after dedicating six years to part-time study while working full-time.